144 related articles for article (PubMed ID: 2132190)
41. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
42. A time-limited, problem-orientated psychotherapeutic intervention in Type 1 diabetic patients with complications: a randomized controlled trial.
Didjurgeit U; Kruse J; Schmitz N; Stückenschneider P; Sawicki PT
Diabet Med; 2002 Oct; 19(10):814-21. PubMed ID: 12358867
[TBL] [Abstract][Full Text] [Related]
43. Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy.
Arner P; Sjöberg S; Gjötterberg M; Skottner A
Diabetologia; 1989 Oct; 32(10):753-8. PubMed ID: 2591643
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of self-reported erectile dysfunction in people with long-term IDDM.
Klein R; Klein BE; Lee KE; Moss SE; Cruickshanks KJ
Diabetes Care; 1996 Feb; 19(2):135-41. PubMed ID: 8718433
[TBL] [Abstract][Full Text] [Related]
45. Sexual function in young women with type 1 diabetes: the METRO study.
Maiorino MI; Bellastella G; Castaldo F; Petrizzo M; Giugliano D; Esposito K
J Endocrinol Invest; 2017 Feb; 40(2):169-177. PubMed ID: 27613610
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of psychological characteristics of Turkish children with type 1 diabetes mellitus from two demographically and geographically distinct regions.
Baran RT; Sürer-Adanır A; Karakurt MN; Dündar M; Aydın M; Özbek MN; Demirbilek H
Turk J Pediatr; 2018; 60(5):554-561. PubMed ID: 30968638
[TBL] [Abstract][Full Text] [Related]
47. A cross-sectional study of glycaemic control, complications and psychosocial functioning among 18- to 35-year-old adults with type 1 diabetes.
Zoffmann V; Vistisen D; Due-Christensen M
Diabet Med; 2014 Apr; 31(4):493-9. PubMed ID: 24236961
[TBL] [Abstract][Full Text] [Related]
48. Semiautomated determination of glycated albumin in glycaemic control of diabetic patients.
Cabre M; Joven J; Simo JM; Matas C; Camps J
Clin Biochem; 1994 Aug; 27(4):307-9. PubMed ID: 8001294
[No Abstract] [Full Text] [Related]
49. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
50. Association between symptoms of depression and glycaemic control may be unstable across gender.
Pouwer F; Snoek FJ
Diabet Med; 2001 Jul; 18(7):595-8. PubMed ID: 11553192
[TBL] [Abstract][Full Text] [Related]
51. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
52. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
[TBL] [Abstract][Full Text] [Related]
53. The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study.
Grant P; Dworakowska D; DeZoysa N; Barnes D
Diabetes Metab; 2013 Oct; 39(5):439-44. PubMed ID: 24076359
[TBL] [Abstract][Full Text] [Related]
54. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
[TBL] [Abstract][Full Text] [Related]
55. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
56. Association of depression and diabetes complications: a meta-analysis.
de Groot M; Anderson R; Freedland KE; Clouse RE; Lustman PJ
Psychosom Med; 2001; 63(4):619-30. PubMed ID: 11485116
[TBL] [Abstract][Full Text] [Related]
57. An estimate of lifetime cognitive change and its relationship with diabetes health in older adults with type 1 diabetes: preliminary results.
Johnston H; McCrimmon R; Petrie J; Astell A
Behav Neurol; 2010; 23(4):165-7. PubMed ID: 21422545
[No Abstract] [Full Text] [Related]
58. Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.
Copur S; Siriopol D; Afsar B; Comert MC; Uzunkopru G; Sag AA; Ortiz A; Covic A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
Acta Diabetol; 2021 Jan; 58(1):81-91. PubMed ID: 32862262
[TBL] [Abstract][Full Text] [Related]
59. Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Whaley-Connell A; Sowers JR
Diabetes; 2014 Jan; 63(1):45-7. PubMed ID: 24357694
[No Abstract] [Full Text] [Related]
60. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
Billault BM; Passa PL
J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]